seed
Stage
2
Investors
About
NeuroNOS is an Israeli biotech developing a novel therapeutic for autism spectrum disorder that targets abnormal nitric oxide signaling. The company is conducting preclinical research aimed at creating a treatment for core ASD symptoms.
Explore NeuroNOS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.